Mannose-binding lectin in obesity with different degrees of metabolic syndrome abnormalities: Association with atherogenic and metabolic traits

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 6, 2012, Pages 539-551

  Strack, Christina ^a   Baessler, Andrea ^a   Wagner, Florian ^a   Bruxmeier, Janine ^a   Yaroslavskii, Oleg ^a   Rousseva, Elena ^a   Loew, Thomas ^a   Riegger, Gunter ^a   Schmitz, Gerd ^a   Fischer, Marcus ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Atherosclerosis; Mannose binding lectin; Metabolic syndrome; Weight reduction

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CD40 ANTIGEN; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANNOSE BINDING LECTIN; RESISTIN; SEROTONIN; TRIACYLGLYCEROL;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROGENESIS; BODY MASS; CALORIMETRY; CARDIOMETABOLIC RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHENOTYPE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; MANNOSE-BINDING LECTINS; METABOLIC SYNDROME X; OBESITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84863553001     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.10918     Document Type: Article

References (44)

1. Despres JP, Lemieux I: Abdominal obesity and MetS. Nature, 2006; 444: 881-887
2. Haslam DW, James WP: Obesity. Lancet, 2005; 366: 1197-1209
3. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I: Adiponectin and MetS. Arterioscler Thromb Vasc Biol, 2004; 24: 29-33
4. Maahs DM, Ogden LG, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson JE, Ehrlich J, Eckel RH, Rewers M: Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation, 2005; 111: 747-753
5. Hansen TK: Mannose-binding lectin (MBL) and vascular complications in diabetes. Horm Metab Res, 2005; 37 Suppl 1: 95-98
6. Thiel S, Vorup-Jensen T, Stover CM, Schwaeble W, Laursen SB, Poulsen K, Willis AC, Eggleton P, Hansen S, Holmskov U, Reid KB, Jensenius JC: A second serine protease associated with mannan-binding lectin that activates complement. Nature, 1997; 386: 506-510
7. Yasojima K, Schwab C, McGeer EG, McGeer PL: Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques. Arterioscler Thromb Vasc Biol, 2001; 21: 1214-1219
8. Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, Witztum JL: Innate and acquired immunity in atherogenesis. Nat Med, 2002; 8: 1218-1226
9. Wang B, Li Q, Jiang Y, Liu Z, Zhong L, Luo R, Cheng Q, Qing H: Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese. Inflamm Res
10. Engstrom G, Hedblad B, Eriksson KF, Janzon L, Lindgarde F: Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes, 2005; 54: 570-575
11. Best LG, Davidson M, North KE, MacCluer JW, Zhang Y, Lee ET, Howard BV, DeCroo S, Ferrell RE: Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study. Circulation, 2004; 109: 471-475
12. Madsen HO, Videm V, Svejgaard A, Svennevig JL, Garred P: Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet, 1998; 352: 959-960
13. Hegele RA, Ban MR, Anderson CM, Spence JD: Infection- susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J Investig Med, 2000; 48: 198-202
14. Limnell V, Aittoniemi J, Vaarala O, Lehtimaki T, Laine S, Virtanen V, Palosuo T, Miettinen A: Association of mannan-binding lectin deficiency with venous bypass graft occlusions in patients with coronary heart disease. Cardiology, 2002; 98: 123-126
15. Pesonen E, Hallman M, Sarna S, Andsberg E, Haataja R, Meri S, Persson K, Puolakkainen M, Ohlin H, Truedsson L: Mannose-binding lectin as a risk factor for acute coronary syndromes. Ann Med, 2009; 41: 591-598
16. Keller TT, van Leuven SI, Meuwese MC, Wareham NJ, Luben R, Stroes ES, Hack CE, Levi M, Khaw KT, Boekholdt SM: Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler Thromb Vasc Biol, 2006; 26: 2345-2350
17. Trendelenburg M, Theroux P, Stebbins A, Granger C, Armstrong P, Pfisterer M: Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J, 2010; 31: 1181-1187
18. Hansen TK, Gall MA, Tarnow L, Thiel S, Stehouwer CD, Schalkwijk CG, Parving HH, Flyvbjerg A: Mannosebinding lectin and mortality in type 2 diabetes. Arch Intern Med, 2006; 166: 2007-2013
19. Fernandez-Real JM, Straczkowski M, Vendrell J, Soriguer F, Perez Del Pulgar S, Gallart L, Lopez-Bermejo A, Kowalska I, Manco M, Cardona F, Garcia-Gil MM, Mingrone G, Richart C, Ricart W, Zorzano A: Protection from inflammatory disease in insulin resistance: the role of mannan-binding lectin. Diabetologia, 2006; 49: 2402-2411
20. Manco M, Fernandez-Real JM, Equitani F, Vendrell J, Valera Mora ME, Nanni G, Tondolo V, Calvani M, Ricart W, Castagneto M, Mingrone G: Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab, 2007; 92: 483-490
21. Nestlé HealthCare Nutrition National Database, 1997, Optifast®, Société des Produits Nestlé S.A., Vevey, Switzerland, URL: http://www.optifast.com/Pages/proven_weight_loss.aspx (on 2011-05-16)
22. Wadden TA, Frey DL: A multicenter evaluation of a proprietary weight loss program for the treatment of marked obesity: a five-year follow-up. Int J Eat Disord, 1997; 22: 203-212
23. Jaffrin MY: Body composition determination by bioimpedance: an update. Curr Opin Clin Nutr Metab Care, 2009; 12: 482-486
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28: 412-419
25. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001; 285: 2486-2497
26. Saevarsdottir S, Oskarsson OO, Aspelund T, Eiriksdottir G, Vikingsdottir T, Gudnason V, Valdimarsson H: Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med, 2005; 201: 117-125
27. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC: Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods, 2000; 241: 33-42
28. Hoeflich C, Unterwalder N, Schuett S, Schmolke K, Boenisch O, Hammer M, Scheufele R, Michael D, Volk HD, Scheibenbogen C, von Baehr V, Meisel C: Clinical manifestation of mannose-binding lectin deficiency in adults independent of concomitant immunodeficiency. Hum Immunol, 2009; 70: 809-812
29. Thiel S, Frederiksen PD, Jensenius JC: Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol, 2006; 43: 86-96
30. Ip WK, Takahashi K, Ezekowitz RA, Stuart LM: Mannose- binding lectin and innate immunity. Immunol Rev, 2009; 230: 9-21
31. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M: Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes, 1998; 47: 1643-1649
32. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G: Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest, 1997; 100: 1166-1173
33. Hauner H, Bramlage P, Losch C, Jockel KH, Moebus S, Schunkert H, Wasem J: Overweight, obesity and high waist circumference: regional differences in prevalence in primary medical care. Dtsch Arztebl Int, 2008; 105: 827-833
34. Ip WK, To YF, Cheng SK, Lau YL: Serum mannose-binding lectin levels and mbl2 gene polymorphisms in different age and gender groups of southern Chinese adults. Scand J Immunol, 2004; 59: 310-314
35. Garred P: Mannose-binding lectin genetics: from A to Z. Biochem Soc Trans, 2008; 36: 1461-1466
36. Dean MM, Minchinton RM, Heatley S, Eisen DP: Mannose binding lectin acute phase activity in patients with severe infection. J Clin Immunol, 2005; 25: 346-352
37. Rugonfalvi-Kiss S, Dosa E, Madsen HO, Endresz V, Prohaszka Z, Laki J, Karadi I, Gonczol E, Selmeci L, Romics L, Fust G, Entz L, Garred P: High rate of early restenosis after carotid eversion endarterectomy in homozygous carriers of the normal mannose-binding lectin genotype. Stroke, 2005; 36: 944-948
38. Matthijsen RA, de Winther MP, Kuipers D, van der Made I, Weber C, Herias MV, Gijbels MJ, Buurman WA: Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation, 2009; 119: 2188-2195
39. Jordan JE, Montalto MC, Stahl GL: Inhibition of mannose- binding lectin reduces postischemic myocardial reperfusion injury. Circulation, 2001; 104: 1413-1418
40. Busche MN, Walsh MC, McMullen ME, Guikema BJ, Stahl GL: Mannose-binding lectin plays a critical role in myocardial ischaemia and reperfusion injury in a mouse model of diabetes. Diabetologia, 2008; 51: 1544-1551
41. Garred P, Larsen F, Madsen HO, Koch C: Mannose-binding lectin deficiency-revisited. Mol Immunol, 2003; 40: 73-84
42. Kilpatrick DC: Mannan-binding lectin and its role in innate immunity. Transfus Med, 2002; 12: 335-352
43. Dommett RM, Klein N, Turner MW: Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens, 2006; 68: 193-209
44. Mellbin LG, Hamsten A, Malmberg K, Steffensen R, Ryden L, Ohrvik J, Hansen TK: Mannose-binding lectin genotype and phenotype in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Diabetes Care, 33: 2451-2456